nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—systemic lupus erythematosus	0.325	1	CbGaD
Lumiracoxib—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.126	0.207	CbGbCtD
Lumiracoxib—PTGS2—Dapsone—systemic lupus erythematosus	0.0717	0.118	CbGbCtD
Lumiracoxib—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0622	0.102	CbGbCtD
Lumiracoxib—PTGS1—Dapsone—systemic lupus erythematosus	0.0606	0.0993	CbGbCtD
Lumiracoxib—PTGS2—Betamethasone—systemic lupus erythematosus	0.0534	0.0874	CbGbCtD
Lumiracoxib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.038	0.0622	CbGbCtD
Lumiracoxib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0342	0.0561	CbGbCtD
Lumiracoxib—PTGS2—Dexamethasone—systemic lupus erythematosus	0.031	0.0509	CbGbCtD
Lumiracoxib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0293	0.0481	CbGbCtD
Lumiracoxib—CYP2C9—Dapsone—systemic lupus erythematosus	0.0244	0.04	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—systemic lupus erythematosus	0.0203	0.0333	CbGbCtD
Lumiracoxib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0193	0.0316	CbGbCtD
Lumiracoxib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.016	0.0263	CbGbCtD
Lumiracoxib—CYP2C9—cardial valve—systemic lupus erythematosus	0.013	0.297	CbGeAlD
Lumiracoxib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0127	0.0208	CbGbCtD
Lumiracoxib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0106	0.0173	CbGbCtD
Lumiracoxib—CYP2C19—urine—systemic lupus erythematosus	0.00363	0.0827	CbGeAlD
Lumiracoxib—CYP1A2—urine—systemic lupus erythematosus	0.00296	0.0676	CbGeAlD
Lumiracoxib—CYP2C9—urine—systemic lupus erythematosus	0.00281	0.0641	CbGeAlD
Lumiracoxib—UGT1A9—kidney—systemic lupus erythematosus	0.00231	0.0527	CbGeAlD
Lumiracoxib—CYP2C19—blood plasma—systemic lupus erythematosus	0.00189	0.0432	CbGeAlD
Lumiracoxib—CYP1A2—blood plasma—systemic lupus erythematosus	0.00155	0.0353	CbGeAlD
Lumiracoxib—PTGS1—endothelium—systemic lupus erythematosus	0.00151	0.0344	CbGeAlD
Lumiracoxib—CYP2C9—blood plasma—systemic lupus erythematosus	0.00147	0.0335	CbGeAlD
Lumiracoxib—UGT1A9—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.00146	0.105	CbGpPWpGaD
Lumiracoxib—PTGS2—endothelium—systemic lupus erythematosus	0.00144	0.0329	CbGeAlD
Lumiracoxib—PTGS1—blood plasma—systemic lupus erythematosus	0.00134	0.0306	CbGeAlD
Lumiracoxib—PTGS2—blood plasma—systemic lupus erythematosus	0.00128	0.0292	CbGeAlD
Lumiracoxib—Bromfenac—PTGS2—systemic lupus erythematosus	0.000806	0.282	CrCbGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000723	0.0521	CbGpPWpGaD
Lumiracoxib—PTGS1—connective tissue—systemic lupus erythematosus	0.000713	0.0163	CbGeAlD
Lumiracoxib—PTGS2—connective tissue—systemic lupus erythematosus	0.000682	0.0155	CbGeAlD
Lumiracoxib—PTGS1—skin of body—systemic lupus erythematosus	0.000644	0.0147	CbGeAlD
Lumiracoxib—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000621	0.159	CbGdCrCtD
Lumiracoxib—PTGS2—skin of body—systemic lupus erythematosus	0.000616	0.014	CbGeAlD
Lumiracoxib—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000612	0.156	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000612	0.156	CbGdCrCtD
Lumiracoxib—PTGS1—kidney—systemic lupus erythematosus	0.000607	0.0138	CbGeAlD
Lumiracoxib—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000598	0.153	CbGdCrCtD
Lumiracoxib—PTGS2—kidney—systemic lupus erythematosus	0.00058	0.0132	CbGeAlD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000574	0.0414	CbGpPWpGaD
Lumiracoxib—Tolmetin—PTGS2—systemic lupus erythematosus	0.000542	0.189	CrCbGaD
Lumiracoxib—CYP1A2—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000534	0.0385	CbGpPWpGaD
Lumiracoxib—Meclofenamic acid—PTGS2—systemic lupus erythematosus	0.000534	0.187	CrCbGaD
Lumiracoxib—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000499	0.0114	CbGeAlD
Lumiracoxib—CYP1A2—lung—systemic lupus erythematosus	0.000496	0.0113	CbGeAlD
Lumiracoxib—PTGS1—tendon—systemic lupus erythematosus	0.00049	0.0112	CbGeAlD
Lumiracoxib—PTGS2—tendon—systemic lupus erythematosus	0.000469	0.0107	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—systemic lupus erythematosus	0.000454	0.0104	CbGeAlD
Lumiracoxib—PTGS1—lung—systemic lupus erythematosus	0.00043	0.00981	CbGeAlD
Lumiracoxib—Mefenamic acid—PTGS2—systemic lupus erythematosus	0.000415	0.145	CrCbGaD
Lumiracoxib—PTGS2—lung—systemic lupus erythematosus	0.000411	0.00938	CbGeAlD
Lumiracoxib—PTGS1—nervous system—systemic lupus erythematosus	0.000398	0.00909	CbGeAlD
Lumiracoxib—PTGS1—central nervous system—systemic lupus erythematosus	0.000384	0.00875	CbGeAlD
Lumiracoxib—PTGS2—nervous system—systemic lupus erythematosus	0.000381	0.00869	CbGeAlD
Lumiracoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000375	0.0957	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000369	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000369	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—central nervous system—systemic lupus erythematosus	0.000367	0.00836	CbGeAlD
Lumiracoxib—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000361	0.0921	CbGdCrCtD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000316	0.0228	CbGpPWpGaD
Lumiracoxib—Diclofenac—PTGS2—systemic lupus erythematosus	0.000298	0.104	CrCbGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.000275	0.0198	CbGpPWpGaD
Lumiracoxib—Diclofenac—ALB—systemic lupus erythematosus	0.000266	0.0929	CrCbGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—RXRA—systemic lupus erythematosus	0.000253	0.0182	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.000235	0.017	CbGpPWpGaD
Lumiracoxib—UGT1A9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000214	0.0155	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000196	0.0142	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000193	0.0139	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000193	0.0139	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000183	0.0132	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000171	0.0123	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—NAT2—systemic lupus erythematosus	0.00017	0.0123	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000168	0.0121	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.00016	0.0115	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000156	0.0112	CbGpPWpGaD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000153	0.0111	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	0.000132	0.00953	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.000132	0.00949	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	0.000129	0.00927	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	0.000123	0.00886	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	0.000118	0.0085	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.000111	0.00798	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.00011	0.00793	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.000109	0.00788	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000102	0.00739	CbGpPWpGaD
Lumiracoxib—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000101	0.00726	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—NAT2—systemic lupus erythematosus	9.95e-05	0.00718	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.82e-05	0.00708	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	9.44e-05	0.00681	CbGpPWpGaD
Lumiracoxib—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	9.18e-05	0.00662	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	9.13e-05	0.00659	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	9.08e-05	0.00655	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	8.89e-05	0.00641	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.56e-05	0.00618	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	8.55e-05	0.00616	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	8.31e-05	0.006	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	8.3e-05	0.00599	CbGpPWpGaD
Lumiracoxib—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	8.23e-05	0.00594	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	8.11e-05	0.00585	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—RXRA—systemic lupus erythematosus	7.98e-05	0.00575	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	7.95e-05	0.00573	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	7.92e-05	0.00571	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	7.81e-05	0.00563	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	7.77e-05	0.00561	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	7.62e-05	0.00549	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	7.54e-05	0.00544	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	7.38e-05	0.00532	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	7.17e-05	0.00517	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	7.07e-05	0.0051	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	7.05e-05	0.00509	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	6.96e-05	0.00502	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	6.91e-05	0.00498	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	6.77e-05	0.00488	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	6.7e-05	0.00483	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	6.62e-05	0.00477	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—RXRA—systemic lupus erythematosus	6.36e-05	0.00459	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	6.23e-05	0.00449	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	6.13e-05	0.00442	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.09e-05	0.00439	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.07e-05	0.00438	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	5.91e-05	0.00426	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	5.76e-05	0.00415	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	5.75e-05	0.00415	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	5.69e-05	0.00411	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—RXRA—systemic lupus erythematosus	5.58e-05	0.00402	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.55e-05	0.004	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.52e-05	0.00398	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	5.38e-05	0.00388	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	5.37e-05	0.00388	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	5.31e-05	0.00383	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—PPARG—systemic lupus erythematosus	5.04e-05	0.00363	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	5.03e-05	0.00363	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.94e-05	0.00356	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	4.93e-05	0.00356	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	4.88e-05	0.00352	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.74e-05	0.00342	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	4.74e-05	0.00342	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.72e-05	0.0034	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	4.68e-05	0.00337	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.61e-05	0.00333	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	4.57e-05	0.0033	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	4.55e-05	0.00328	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	4.5e-05	0.00325	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.5e-05	0.00325	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	4.47e-05	0.00322	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	4.41e-05	0.00318	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	4.28e-05	0.00309	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	4.27e-05	0.00308	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	4.22e-05	0.00304	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.21e-05	0.00303	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	4.18e-05	0.00302	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.06e-05	0.00293	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	4.03e-05	0.00291	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.02e-05	0.0029	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	3.86e-05	0.00279	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.85e-05	0.00277	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.79e-05	0.00273	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	3.76e-05	0.00271	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	3.64e-05	0.00263	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.59e-05	0.00259	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	3.5e-05	0.00253	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.5e-05	0.00252	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.48e-05	0.00251	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	3.47e-05	0.0025	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	3.4e-05	0.00245	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.32e-05	0.00239	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	3.3e-05	0.00238	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	3.25e-05	0.00235	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	3.23e-05	0.00233	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	3.21e-05	0.00231	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	3.2e-05	0.00231	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.19e-05	0.0023	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	3.04e-05	0.00219	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	3.01e-05	0.00217	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	2.97e-05	0.00215	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	2.91e-05	0.0021	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	2.78e-05	0.00201	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	2.76e-05	0.00199	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.76e-05	0.00199	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.73e-05	0.00197	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.72e-05	0.00196	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	2.7e-05	0.00195	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	2.65e-05	0.00191	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.62e-05	0.00189	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	2.62e-05	0.00189	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.61e-05	0.00188	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.55e-05	0.00184	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	2.53e-05	0.00182	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.42e-05	0.00175	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.42e-05	0.00175	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	2.39e-05	0.00172	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	2.3e-05	0.00166	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.3e-05	0.00166	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.28e-05	0.00165	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	2.25e-05	0.00162	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	2.22e-05	0.0016	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.14e-05	0.00155	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	2.13e-05	0.00153	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.11e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.1e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.07e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.04e-05	0.00147	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	1.97e-05	0.00142	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.97e-05	0.00142	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.75e-05	0.00126	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.75e-05	0.00126	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	1.7e-05	0.00123	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.67e-05	0.0012	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.64e-05	0.00118	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.63e-05	0.00118	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.56e-05	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.44e-05	0.00104	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.39e-05	0.001	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.39e-05	0.001	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.37e-05	0.000989	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.35e-05	0.000976	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.32e-05	0.000953	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.3e-05	0.000937	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.22e-05	0.000877	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.2e-05	0.000868	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.19e-05	0.00086	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CSK—systemic lupus erythematosus	1.17e-05	0.000846	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.11e-05	0.000803	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.1e-05	0.000795	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD247—systemic lupus erythematosus	1.1e-05	0.000795	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.1e-05	0.000794	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.07e-05	0.000773	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.06e-05	0.000768	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.01e-05	0.000726	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.92e-06	0.000715	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	9.54e-06	0.000688	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.18e-06	0.000662	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.85e-06	0.000638	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.75e-06	0.000631	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.67e-06	0.000626	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JUNB—systemic lupus erythematosus	8.41e-06	0.000607	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	8e-06	0.000577	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.87e-06	0.000568	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.85e-06	0.000566	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	7.78e-06	0.000561	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRL—systemic lupus erythematosus	7.75e-06	0.000559	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	7.29e-06	0.000526	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.21e-06	0.00052	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.36e-06	0.000459	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	6.23e-06	0.00045	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAK1—systemic lupus erythematosus	6.2e-06	0.000447	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	6.17e-06	0.000445	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	6.02e-06	0.000435	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CCR5—systemic lupus erythematosus	5.87e-06	0.000424	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.8e-06	0.000418	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.73e-06	0.000413	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.72e-06	0.000412	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	5.42e-06	0.000391	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.21e-06	0.000376	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	5.18e-06	0.000374	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5e-06	0.000361	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.95e-06	0.000357	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	4.91e-06	0.000354	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—systemic lupus erythematosus	4.83e-06	0.000349	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	4.74e-06	0.000342	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.56e-06	0.000329	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	4.48e-06	0.000323	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.45e-06	0.000321	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—systemic lupus erythematosus	4.42e-06	0.000319	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	4.22e-06	0.000305	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.16e-06	0.0003	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	4.09e-06	0.000295	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TYK2—systemic lupus erythematosus	4.08e-06	0.000294	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—systemic lupus erythematosus	4e-06	0.000289	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	3.94e-06	0.000284	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	3.9e-06	0.000281	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.9e-06	0.000281	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	3.86e-06	0.000279	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.79e-06	0.000274	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—systemic lupus erythematosus	3.69e-06	0.000266	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—systemic lupus erythematosus	3.51e-06	0.000253	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3.49e-06	0.000252	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	3.47e-06	0.00025	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	3.35e-06	0.000242	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.24e-06	0.000234	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—EP300—systemic lupus erythematosus	3.21e-06	0.000232	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	3.2e-06	0.000231	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EP300—systemic lupus erythematosus	3.05e-06	0.00022	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.83e-06	0.000204	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—systemic lupus erythematosus	2.65e-06	0.000191	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.58e-06	0.000186	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—EP300—systemic lupus erythematosus	2.55e-06	0.000184	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.55e-06	0.000184	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	2.44e-06	0.000176	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	2.32e-06	0.000167	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	2.23e-06	0.000161	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	2.22e-06	0.00016	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.21e-06	0.000159	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	2.03e-06	0.000146	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—systemic lupus erythematosus	2e-06	0.000144	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.98e-06	0.000143	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.9e-06	0.000137	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.85e-06	0.000134	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.74e-06	0.000125	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.69e-06	0.000122	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.44e-06	0.000104	CbGpPWpGaD
